Page last updated: 2024-11-08

biperiden lactate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID197083
CHEMBL ID1201067
SCHEMBL ID41834
MeSH IDM0110997

Synonyms (31)

Synonym
einecs 230-388-9
biperiden lactate
akineton
lactic acid, compound with alpha-bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenylpiperidin-1-propanol (1:1)
alpha-5-norbornen-2-yl-alpha-phenyl-1-piperidinepropanol lactate (salt)
akineton lactate
tasmolin (tn)
biperiden lactate (jan/usp)
D02247
CHEMBL1201067
biperiden lactate [usp:ban:jan]
09td6c5147 ,
unii-09td6c5147
biperiden lactate [who-dd]
biperiden lactate [orange book]
biperiden lactate [vandf]
biperiden lactate [mart.]
biperiden lactate [jan]
biperiden lactate [usp impurity]
SCHEMBL41834
biperidenlactate
HY-13204B
biperidenlactat
DTXSID40991120
Q27236503
1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol;2-hydroxypropanoic acid
CS-0030940
biperiden lactate (mart.)
biperidene lactate
biperiden lactate (usp impurity)
AKOS040750804
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.12 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (40.00%)4.05%
Observational0 (0.00%)0.25%
Other2 (40.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Use of Biperiden as a Disease Modifying Agent After Traumatic Brain Injury: a Placebo Controlled, Randomized, Double Blind Study [NCT01048138]Phase 3123 participants (Actual)Interventional2018-01-31Terminated(stopped due to Recruitment and funding issues, together with the event of the SARS-CoV-2 pandemic prompted an adjustment in the study design to stop enrollment at 123 patients.)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]